Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compounds

Drug Discov Today. 2022 Jun;27(6):1733-1742. doi: 10.1016/j.drudis.2022.03.008. Epub 2022 Mar 14.

Abstract

Compounds that exhibit assay interference or undesirable mechanisms of bioactivity are routinely encountered in assays at various stages of drug discovery. We observed that assays for the investigation of thiol-reactive and redox-active compounds have not been collected in a comprehensive review. Here, we review these assays and subject them to experimental optimization to improve their reliability. We demonstrate the usefulness of our assay cascade by assaying a library of bioactive compounds, chemical probes, and a set of approved drugs. These high-throughput assays should complement the array of wet-lab and in silico assays during the initial stages of hit discovery campaigns to pursue only hit compounds with tractable mechanisms of action.

Keywords: Assays; Covalent; Hits; PAINS; Redox; Screening.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Discovery
  • High-Throughput Screening Assays*
  • Oxidation-Reduction
  • Reproducibility of Results
  • Sulfhydryl Compounds* / chemistry

Substances

  • Sulfhydryl Compounds